Daily hospice: Depression and anxiety after mastectomy for breast cancer

The aim of the study was to define the effects of daily hospice team's activities on depression and anxiety in breast cancer patients having undergone mastectomy after three-month therapy. This prospective study included 35 patients that underwent mastectomy for breast cancer, followed by 3-month treatment at daily hospice, Tuzla University Clinical Center. Control group consisted of 35 mastectomized patients that did not visit daily hospice. Depression and anxiety were estimated by use of Zung's scale. Patients were tested initially and retested at 12 weeks. On initial testing, the mean value of depression was 59.85 +/- 6.97 in the study group and 55.65 +/- 7.91 in the control group. On three-month retesting, the level of depression was lower in the study group, with a mean value of 48.57 +/- 7.06 (P<0.0001) (steam T-test and Wilcoxon's test) and higher in the control group, with a mean value of 60.45 +/- 7.47 (P=0.0001) (steam T-test and Wilcoxon's test). On initial testing, the mean value of anxiety was 54.97 +/- 6.35 and 52.20 +/- 6.03 in the study and control group, respectively. On three-month retesting, the level of anxiety was lower in the study group, with a mean value of 43.43 +/- 5.97 (P<0.0001), showing improvement from initial testing, but was higher in the control group, with a mean value of 55.68 +/- 7.47 (P=0.0002). In conclusion, daily hospice team's treatment had favorable effects on lowering the levels of depression and anxiety in patients undergoing mastectomy for breast cancer.